- Home
- CNTX vs SVIAW Comparison
CNTX vs SVIAW Comparison
Compare CNTX & SVIAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.24
Company Overview
Basic Information| Metric | CNTX | SVIAW |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 39.1M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CNTX | SVIAW |
|---|---|---|
| Price | $0.24 | $0.50 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $4.14 | N/A |
| AVG Volume (30 Days) | ★ 971.2K | 36.8K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.36 |
| 52 Week High | $3.62 | $0.60 |
Technical Indicators
Market Signals| Indicator | CNTX | SVIAW |
|---|---|---|
| Relative Strength Index (RSI) | 29.57 | 55.26 |
| Support Level | N/A | $0.38 |
| Resistance Level | $0.36 | N/A |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 23.87 | 81.79 |
Price Performance
Historical Comparison CNTX
SVIAW
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.